Takata Obtains Pediatric Indication For Anti-Allergy Drug Cetirizine
This article was originally published in PharmAsia News
Executive Summary
Takata Seiyaku has obtained approval for the pediatric indication of Takata (cetirizine) for the treatment of allergies, the company announced Sept. 3.